Transaction in Own Shares

Summary by AI ^BETAClose X

Legal & General Group Plc has purchased 6,061,919 of its ordinary shares between June 29, 2026, and July 3, 2026, as part of its share buyback program announced on March 11, 2026. These repurchased shares will be cancelled, resulting in a new total of 5,535,403,282 ordinary shares in issue and an equivalent number of voting rights, as no shares are held in treasury. The purchases were executed through the company's broker, Barclays Capital Securities Limited, with prices ranging from 283.70 pence to 292.90 pence per share.

Disclaimer*

Legal & General Group Plc

06 July 2026

LEGAL & GENERAL GROUP PLC
ISIN: GB0005603997
6^th July 2026

LEI number: 213800JH9QQWHLO99821

Legal & General Group Plc (the "Company")
Transaction in Own Shares

The Company announces that from 29^th June 2026 up to and including 3^rd July 2026 it had purchased a total of 6,061,919 of its ordinary shares of 2.5 pence each (the "ordinary shares"), through the Company's broker Barclays Capital Securities Limited as detailed below. The repurchased ordinary shares will be cancelled.

Date	Aggregate number of ordinary shares purchased	Highest price paid (per ordinary share)	Lowest price paid (per ordinary share)	Volume weighted average price	Trading venue
29^th June 2026	308,552	286.10	284.80	285.52	XLON
29^th June 2026	159,222	286.10	284.70	285.38	BATE
29^th June 2026	166,264	286.10	284.80	285.44	TRQX
29^th June 2026	63,866	286.10	284.90	285.57	AQXE
29^th June 2026	302,096	286.10	284.80	285.45	CHIX
30^th June 2026	33,880	285.30	285.10	285.19	XLON
30^th June 2026	17,334	285.30	285.10	285.24	BATE
30^th June 2026	21,247	285.30	285.10	285.22	TRQX
30^th June 2026	14,235	285.40	285.00	285.18	AQXE
30^th June 2026	36,832	285.40	285.10	285.24	CHIX
1^st July 2026	833,527	286.90	283.80	285.60	XLON
1^st July 2026	227,849	286.90	283.70	285.60	BATE
1^st July 2026	217,791	286.90	283.70	285.60	TRQX
1^st July 2026	322,248	286.90	284.40	285.61	AQXE
1^st July 2026	396,936	286.90	283.70	285.59	CHIX
2^nd July 2026	449,366	289.00	287.00	288.48	XLON
2^nd July 2026	75,088	289.00	287.00	288.56	BATE
2^nd July 2026	103,698	289.00	287.00	288.52	TRQX
2^nd July 2026	119,520	289.00	287.10	288.66	AQXE
2^nd July 2026	192,368	289.00	287.00	288.46	CHIX
3^rd July 2026	969,582	292.70	290.00	291.30	XLON
3^rd July 2026	235,707	292.90	290.00	291.31	BATE
3^rd July 2026	218,423	292.90	290.00	291.34	TRQX
3^rd July 2026	172,641	292.70	290.00	291.21	AQXE
3^rd July 2026	403,647	292.90	290.00	291.30	CHIX

The purchases form part of the Company's share buyback programme announced on 11^th March 2026.

Following settlement of the above purchases and cancellation of the purchased ordinary shares, the Company's total number of ordinary shares in issue shall be 5,535,403,282 ordinary shares.

No ordinary shares are held in treasury. Therefore, the total number of voting rights in the Company is 5,535,403,282.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as incorporated into and implemented under English law (including by virtue of the European Union (Withdrawal) Act 2018), the detailed breakdown of individual trades made by Barclays Capital Securities Limited on behalf of the Company as part of the share buyback programme is set out below.

http://www.rns-pdf.londonstockexchange.com/rns/1593L_1-2026-7-6.pdf

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END